Biotechnology - Kineret

Filter

Current filters:

Kineret

Popular Filters

SOBI restructures Kineret and Kepivance deals

09-09-2013

Swedish Orphan Biovitrum (STO: SOBI) said this morning that it has acquired the full rights to develop…

AmgenAnti-Arthritics/RheumaticsBiotechnologyKepivanceKineretLicensingOncologyPharmaceuticalRare diseasesSwedish Orphan Biovitrum

FDA approves SOBI's Kineret for the treatment of NOMID

08-01-2013

Biotech firm Swedish Orphan Biovitrum (STO: SOBI) today announced that the US Food and Drug Administration…

AmgenBiotechnologyInflammatory diseasesKineretNorth AmericaRegulationSobiSwedish Orphan Biovitrum

Kineret halts organ damage in inflammatory genetic disorder

13-02-2012

A new study shows that Kineret (anakinra), a drug developed by US biotech giant Amgen (Nasdaq: AMGN)…

AmgenBiotechnologyKineretPharmaceuticalRare diseasesResearch

Back to top